Related Experiment Video

Updated: Aug 15, 2026

Mouse Model of Acute to Chronic Kidney Disease Transition Induced by Renal Ischemia/Reperfusion Injury
07:02

Mouse Model of Acute to Chronic Kidney Disease Transition Induced by Renal Ischemia/Reperfusion Injury

Published on: February 10, 2026

Epidemiology of pediatric chronic kidney disease

Vimal Chadha1, Bradley A Warady

  • 1Section of Nephrology, Virginia Commonwealth University Medical Center, Richmond, VA, USA.

Advances in Chronic Kidney Disease
|October 4, 2005
PubMed

Insights

Epidemiological data for pediatric chronic kidney disease (CKD) is imprecise. Congenital abnormalities and obstructive uropathy are leading causes, with geographic variations influencing CKD prevalence and treatment, often favoring transplantation.

Area of Science:

  • Pediatric Nephrology
  • Epidemiology
  • Public Health

Background:

  • Epidemiological data on pediatric chronic kidney disease (CKD) lacks precision, unlike adult CKD registries.
  • Methodological differences across data sources contribute to flawed pediatric CKD epidemiology.
  • Congenital anomalies and obstructive uropathy are primary causes of CKD in children, leading to early renal insufficiency.

Purpose of the Study:

  • To highlight the imprecise nature of current pediatric CKD epidemiological data.
  • To underscore the significant impact of congenital abnormalities and obstructive uropathy on pediatric CKD.
  • To emphasize the need for standardized global epidemiological studies in pediatric CKD.

Main Methods:

  • Review of existing epidemiological data and registries for pediatric CKD.
  • Analysis of reported causes and geographic variations in pediatric CKD.
  • Comparison of CKD prevalence and incidence rates across different healthcare resource settings.

Main Results:

  • Obstructive uropathy and congenital malformations account for nearly half of pediatric CKD cases.
  • Significant geographic disparities exist in reported causes of pediatric CKD due to environmental, genetic, and cultural factors.
  • High mortality rates in low-resource countries lead to lower reported prevalence of pediatric CKD despite comparable incidence.

Conclusions:

  • Standardized global epidemiological studies are crucial for a comprehensive understanding of pediatric CKD.
  • Addressing geographic and resource-related differences is essential for effective intervention strategies.
  • Renal transplantation is the preferred treatment for pediatric CKD where renal replacement therapy is accessible.

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...